Silencing of LOX in these cells resulted in suppressed growth and osteoblast differentiation, supporting the conclusion that interference with LOX expression in inflammatory conditions such as diabetes, osteoporosis and rheumatoid arthritis may result in a diminishing pluripotent cell pool, a condition known to also contribute to osteopenia [60]. The gene discussed is LOX; the disease is osteoporosis.